Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.
about
Effect of second-generation antipsychotics on cognition: current issues and future challenges.Development of abbreviated eight-item form of the Penn Verbal Reasoning Test.Neurobiology of cognitive remediation therapy for schizophrenia: a systematic reviewA brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians.Neurocognition in early-onset schizophrenia and schizoaffective disorders.Sequential processing deficits in schizophrenia: relationship to neuropsychology and genetics.Implementation considerations for multisite clinical trials with cognitive neuroscience tasks.Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.Cognitive impairments in psychotic disorders: common mechanisms and measurement.A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia.
P2860
Q33888153-96F23A23-410A-4A3E-938D-2B6CED86189BQ34090582-FD252A31-B096-4CA0-BCE4-B9F520569783Q34436237-3BC93B83-05E2-4410-9BBC-C9689C4D9AF6Q34830686-10B4A278-A02D-4DB8-B48B-999640F90A41Q35659746-1A4BD877-8A9D-4360-BF61-5486F262ACE1Q35775782-4355F615-8AC9-4CC8-AF4F-141AB22BF512Q37170027-B6CFB3D2-616E-479B-8076-4E324328E572Q37580487-B4A739BF-723C-4654-9230-8F1764DD05E5Q37648920-4B3D3519-8088-4ACF-A896-5A789D3AFEF2Q37699383-FCD94747-610B-4FFF-941E-585398084258Q38171876-537288BF-D4A9-4681-AEFD-AEB6B55BEAE9Q42973967-B50E6844-5B81-4461-8F9A-172ABEA67FE9Q44183552-4D710D0B-F426-4EA0-BCD4-505E2348BB60Q44980410-BD21B84D-E49E-478D-AF63-4E723D0EBF74Q47785459-74A9BAAF-8D20-49F0-BF54-7910EC74774F
P2860
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficiency of the CATIE and BA ...... c treatments in schizophrenia.
@ast
Efficiency of the CATIE and BA ...... c treatments in schizophrenia.
@en
type
label
Efficiency of the CATIE and BA ...... c treatments in schizophrenia.
@ast
Efficiency of the CATIE and BA ...... c treatments in schizophrenia.
@en
prefLabel
Efficiency of the CATIE and BA ...... c treatments in schizophrenia.
@ast
Efficiency of the CATIE and BA ...... c treatments in schizophrenia.
@en
P2093
P2860
P1476
Efficiency of the CATIE and BA ...... c treatments in schizophrenia.
@en
P2093
Diana O Perkins
Hongbin Gu
Jeffrey A Lieberman
John A Sweeney
Joseph P McEvoy
Richard S E Keefe
Robert M Hamer
S Kristian Hill
P2860
P304
P356
10.1017/S1355617708080570
P577
2008-03-01T00:00:00Z